211 related articles for article (PubMed ID: 32120324)
1. American Registry of Pathology Expert Opinions: The Spectrum of Lobular Carcinoma in Situ: Diagnostic Features and Clinical Implications.
Schnitt SJ; Brogi E; Chen YY; King TA; Lakhani SR
Ann Diagn Pathol; 2020 Apr; 45():151481. PubMed ID: 32120324
[TBL] [Abstract][Full Text] [Related]
2. E-cadherin immunohistochemistry in breast pathology: uses and pitfalls.
Canas-Marques R; Schnitt SJ
Histopathology; 2016 Jan; 68(1):57-69. PubMed ID: 26768029
[TBL] [Abstract][Full Text] [Related]
3. The florid subtype of lobular carcinoma in situ: marker or precursor for invasive lobular carcinoma?
Bagaria SP; Shamonki J; Kinnaird M; Ray PS; Giuliano AE
Ann Surg Oncol; 2011 Jul; 18(7):1845-51. PubMed ID: 21287281
[TBL] [Abstract][Full Text] [Related]
4. Evaluating agreement, histological features, and relevance of separating pleomorphic and florid lobular carcinoma in situ subtypes.
Singh K; Paquette C; Kalife ET; Wang Y; Mangray S; Quddus MR; Steinhoff MM
Hum Pathol; 2018 Aug; 78():163-170. PubMed ID: 29753007
[TBL] [Abstract][Full Text] [Related]
5. Differential diagnosis of solid carcinoma in situ.
Maluf HM
Semin Diagn Pathol; 2004 Feb; 21(1):25-31. PubMed ID: 15074556
[TBL] [Abstract][Full Text] [Related]
6. Use of immunohistochemistry in the diagnosis of problematic breast lesions.
Lee AH
J Clin Pathol; 2013 Jun; 66(6):471-7. PubMed ID: 23486609
[TBL] [Abstract][Full Text] [Related]
7. Risk of invasive breast carcinoma among women diagnosed with ductal carcinoma in situ and lobular carcinoma in situ, 1988-2001.
Li CI; Malone KE; Saltzman BS; Daling JR
Cancer; 2006 May; 106(10):2104-12. PubMed ID: 16604564
[TBL] [Abstract][Full Text] [Related]
8. Lobular carcinoma in situ and infiltrating ductal carcinoma: frequent presence of DCIS as a precursor lesion.
Maluf H; Koerner F
Int J Surg Pathol; 2001 Apr; 9(2):127-31. PubMed ID: 11484500
[TBL] [Abstract][Full Text] [Related]
9. Differential expression of E-cadherin in lobular and ductal neoplasms of the breast and its biologic and diagnostic implications.
Acs G; Lawton TJ; Rebbeck TR; LiVolsi VA; Zhang PJ
Am J Clin Pathol; 2001 Jan; 115(1):85-98. PubMed ID: 11190811
[TBL] [Abstract][Full Text] [Related]
10. Clinicopathologic implications of E-cadherin reactivity in patients with lobular carcinoma in situ of the breast.
Goldstein NS; Kestin LL; Vicini FA
Cancer; 2001 Aug; 92(4):738-47. PubMed ID: 11550142
[TBL] [Abstract][Full Text] [Related]
11. Lobular carcinoma in situ: diagnostic criteria and molecular correlates.
Sokolova A; Lakhani SR
Mod Pathol; 2021 Jan; 34(Suppl 1):8-14. PubMed ID: 33024303
[TBL] [Abstract][Full Text] [Related]
12. Interobserver variability and aberrant E-cadherin immunostaining of lobular neoplasia and infiltrating lobular carcinoma.
Choi YJ; Pinto MM; Hao L; Riba AK
Mod Pathol; 2008 Oct; 21(10):1224-37. PubMed ID: 18587329
[TBL] [Abstract][Full Text] [Related]
13. Disparate E-cadherin mutations in LCIS and associated invasive breast carcinomas.
Rieger-Christ KM; Pezza JA; Dugan JM; Braasch JW; Hughes KS; Summerhayes IC
Mol Pathol; 2001 Apr; 54(2):91-7. PubMed ID: 11322170
[TBL] [Abstract][Full Text] [Related]
14. Mixed ductal-lobular carcinomas: evidence for progression from ductal to lobular morphology.
McCart Reed AE; Kutasovic JR; Nones K; Saunus JM; Da Silva L; Newell F; Kazakoff S; Melville L; Jayanthan J; Vargas AC; Reid LE; Beesley J; Chen XQ; Patch AM; Clouston D; Porter A; Evans E; Pearson JV; Chenevix-Trench G; Cummings MC; Waddell N; Lakhani SR; Simpson PT
J Pathol; 2018 Apr; 244(4):460-468. PubMed ID: 29344954
[TBL] [Abstract][Full Text] [Related]
15. Lobular carcinoma, not only a classic.
Brogi E; Murray MP; Corben AD
Breast J; 2010; 16 Suppl 1():S10-4. PubMed ID: 21050299
[TBL] [Abstract][Full Text] [Related]
16. Long term clinical follow-up of atypical ductal hyperplasia and lobular carcinoma in situ in breast core needle biopsies.
Renshaw AA; Gould EW
Pathology; 2016 Jan; 48(1):25-9. PubMed ID: 27020205
[TBL] [Abstract][Full Text] [Related]
17. [Noninvasive breast carcinomas: anatomicopathological, diagnostic and therapeutic findings].
Calabrese L
Acta Biomed Ateneo Parmense; 1998; 69(3-4):113-21. PubMed ID: 10503071
[TBL] [Abstract][Full Text] [Related]
18. The morphologic spectrum of lobular carcinoma in situ (LCIS) observations on clinical significance, management implications and diagnostic pitfalls of classic, florid and pleomorphic LCIS.
Brogi E
Virchows Arch; 2022 Dec; 481(6):823-837. PubMed ID: 35567633
[TBL] [Abstract][Full Text] [Related]
19. How Do We Approach Benign Proliferative Lesions?
Nakhlis F
Curr Oncol Rep; 2018 Mar; 20(4):34. PubMed ID: 29572753
[TBL] [Abstract][Full Text] [Related]
20. Dataset for pathology reporting of ductal carcinoma in situ, variants of lobular carcinoma in situ and low-grade lesions: recommendations from the International Collaboration on Cancer Reporting (ICCR).
Fox SB; Webster F; Chen CJ; Chua B; Collins L; Foschini MP; Bruce Mann G; Millar E; Pinder SE; Rakha E; Shaaban A; Tan BY; Tse G; Watson P; Tan PH
Histopathology; 2022 Oct; 81(4):467-476. PubMed ID: 35869801
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
